Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Hsp90 is a molecular chaperone for many signal transducers and may influence evolution by releasing previously silent genetic variation in response to environmental change. In fungi separated by ∼800 million years of evolution, Hsp90 potentiated the evolution of drug resistance in a different way, by enabling new mutations to have immediate phenotypic consequences. Resistance was abrogated by Hsp90 inhibitors and by febrile temperatures, suggesting new therapeutic strategies and a clinical benefit of fever. During selection in a human host, drug resistance that was initially Hsp90-dependent evolved toward independence. Thus, Hsp90 can act in diverse ways to couple environmental contingency to the emergence and fixation of new traits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibitors of heat shock protein 90 (Hsp90)82, calcineurin21,25,26, target of rapamycin (TOR)83 and mutants that affect Rim10184 (a transcription factor involved in the pH response pathway) effectively eliminate tolerance and greatly increase the fungicidal activity [G] of fluconazole across a diverse set of isolates with different tolerance levels (Fig. 1E; Box 5).”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [82]
In the citing paper
“The importance of rendering FLC fungicidal in treating IFIs arises from the increasing prevalence of acquired FLC resistance and the persistent nature of fungal infections attributed to the fungistatic properties of FLC [10,11,12].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [10]
In the citing paper
“When large numbers of cells are plated on a high concentration of fluconazole, a rapid adaptation to decreased susceptibility has been observed in wild-type cells (25).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [25]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
42 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Self-citationPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Hsp90 as a capacitor of phenotypic variation
Queitsch, C., Sangster, T. A., & Lindquist, S. (2002) · Nature · doi:10.1038/nature749 · Cited by 1,372
Self-citationClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Kirschner, M., & Gerhart, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8420 · Cited by 1,129
Molecular Evidence for the Early Colonization of Land by Fungi and Plants
Heckman, D. S., Geiser, D. M., Eidell, B. R., Stauffer, R. L., Kardos, N. L., & Hedges, S. B. (2001) · Science · doi:10.1126/science.1061457 · Cited by 1,020
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Young, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 822
Research works printed but not linked: 1
- J. R. Blankenship, W. J. Steinbach, J. R. Perfect, J. Heitman, Curr. Opin. Investig. Drugs4, 192 (2003).
Cited by
Items 201–300 of 705
Medically Important Fungi Respond to Azole Drugs: An Update
Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 69
Rein, T. (2016) · BioEssays · doi:10.1002/bies.201600050 · Cited by 78
Vincent, B. M., Langlois, J.-B., Srinivas, R., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., Tidor, B., Buchwald, S. L., & Lindquist, S. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.06.016 · Cited by 58
“…by 10μM Inz-1 to that of other small molecules that sensitize C. albicans to azoles, including inhibitors of Hsp90, Calcineurin, PKC, histone deacetylases, PKA, and ARF cycling (Cowen and Lindquist, 2005; Epp et al., 2010; LaFayette et al., 2010; Marchetti et al., 2000; Smith and Edlind, 2002).”
Self-citationLamoth, F., Juvvadi, P. R., Gehrke, C., Asfaw, Y. G., & Steinbach, W. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit530 · Cited by 62
“albicans [4, 5, 35] was not obvious in our work on A.”
BackgroundGenome-Wide Analysis of Sterol-Lipid Storage and Trafficking in Saccharomyces cerevisiae
Fei, W., Alfaro, G., Muthusamy, B.-P., Klaassen, Z. W. A., Graham, T. R., Yang, H., & Beh, C. T. (2007) · Eukaryotic Cell · doi:10.1128/ec.00386-07 · Cited by 70
Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors
Huang, D. S., LeBlanc, E. V., Shekhar-Guturja, T., Robbins, N., Krysan, D. J., Pizarro, J., Whitesell, L., Cowen, L. E., & Brown, L. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00826 · Cited by 61
Self-citationNovel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes
Qadri, H., Shah, A. H., & Mir, M. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666201228123212 · Cited by 76
Epigenetic gene silencing alters the mechanisms and rate of evolutionary adaptation
Stajic, D., Perfeito, L., & Jansen, L. E. T. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0781-2 · Cited by 63
Epp, E., Vanier, G., Harcus, D., Lee, A. Y., Jansen, G., Hallett, M., Sheppard, D. C., Thomas, D. Y., Munro, C. A., Mullick, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000753 · Cited by 61
“Second, consistent with previous observations that long term azole resistance evolves towards HSP90/calcineurin-independency [20], cells treated with calcineurin inhibitors plus FCZ recover after prolonged incubation, while BFA/FCZ treated cells do not.”
BackgroundLeach, M. D., Tyc, K. M., Brown, A. J. P., & Klipp, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032467 · Cited by 61
“Third, antifungal drug resistance is abrogated both by Hsp90 inhibitors and by elevated temperatures equivalent to those in febrile patients [22].”
BackgroundA Call to Arms: Quest for a Cryptococcal Vaccine
Caballero Van Dyke, M. C., & Wormley, F. L. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.10.002 · Cited by 61
Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis
Lamoth, F., Juvvadi, P. R., & Steinbach, W. J. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00096 · Cited by 65
“Hsp90 was shown to be essential for fungal survival and to be an important trigger of antifungal resistance to both azole and echinocandin classes and possibly to amphotericin B (Cowen and Lindquist, 2005; Cowen et al., 2009; Singh et al., 2009; Lamoth et al., 2012, 2014b; Blum et al., 2013).”
BackgroundHof, H. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.01.001 · Cited by 60
Shekhar‐Guturja, T., Tebung, W. A., Mount, H. O., Liu, N.-N., Köhler, J. R., Whiteway, M. S., & Cowen, L. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01959-16 · Cited by 63
“(Sarstedt), as previously described (4).”
Self-citationKhandelwal, N. K., Chauhan, N., Sarkar, P., Esquivel, B. D., Coccetti, P., Singh, A., Coste, A. T., Gupta, M., Sanglard, D., White, T. C., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807032 · Cited by 59
“Hsp90 is a molecular chaperone that plays a crucial role in antifungal drug resistance (50).”
BackgroundProduction of 1-decanol by metabolically engineered Yarrowia lipolytica
Rutter, C. D., & Rao, C. V. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.07.011 · Cited by 62
Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2
Caplan, T., Lorente-Macías, Á., Stogios, P. J., Evdokimova, E., Hyde, S., Wellington, M. A., Liston, S., Iyer, K. R., Puumala, E., Shekhar-Guturja, T., et al. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.12.008 · Cited by 57
“Targeting Hsp90 with pharmacological inhibitors such as geldanamycin abrogates resistance to echinocandins and azoles (Cowen and Lindquist, 2005; Singh et al., 2009), and genetic compromise of Hsp90 enhances azole efficacy in a mouse model of disseminated candidiasis (Cowen et al.”
BackgroundSelf-citationChatterjee, S., & Tatu, U. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005836 · Cited by 57
Li, C., Tu, J., Han, G., Liu, N., & Sheng, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113961 · Cited by 65
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones
Kang, B. H., & Altieri, D. C. (2009) · Oncogene · doi:10.1038/onc.2009.227 · Cited by 59
“This pathway is exploited in cancer, where Hsp90 chaperoning (Whitesell and Lindquist, 2005), contributes to drug resistance (Cowen and Lindquist, 2005), metastasis (Eustace et al.”
BackgroundHeat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., & Steinbach, W. J. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.947239 · Cited by 81
Bui, D., Lee, Y., Lim, J. Y., Fu, M., Kim, J.-C., Choi, G. J., Son, H., & Lee, Y. (2016) · Scientific Reports · doi:10.1038/srep28154 · Cited by 66
Kim, J., Cho, Y.-J., Do, E., Choi, J., Hu, G., Cadieux, B., Chun, J., Lee, Y., Kronstad, J. W., & Jung, W. H. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.08.006 · Cited by 53
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 62
Stress‐induced evolution of herbicide resistance and related pleiotropic effects
Dyer, W. E. (2018) · Pest Management Science · doi:10.1002/ps.5043 · Cited by 67
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
“Previous studies also identified the role of cellular stress protein in various antifungal drug resistance in Candida species [114].”
BackgroundHeat shock protein 90 from neglected protozoan parasites
Roy, N., Nageshan, R. K., Ranade, S., & Tatu, U. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.003 · Cited by 55
Dannaoui, É., & Espinel‐Ingroff, A. (2019) · Journal of Fungi · doi:10.3390/jof5040108 · Cited by 64
“Filamentous Fungi Correlation between gradient trip and ref rence microdilution methods for filamentous fungi ha been mostly evaluated for Aspergillus spp. [23,44,56–78], Fusarium pp. [60,63,65,66,68,73,76,79– 82], Scedosporium spp. [60,63,66,73,76,83], and Mucorales species [44,63,65,66, 3, 6,81, 4–86]. broth referen…”
MethodInfluentialErg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans
de Oliveira, F. F. M., Paes, H. C., Peconick, L. D. F., Fonseca, F. L., Marina, C. L., Bocca, A. L., Homem-de-Mello, M., Rodrigues, M. L., Albuquerque, P., Nicola, A. M., et al. (2020) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2020.103368 · Cited by 58
“The evolved mechanisms include alteration of ergosterol biosynthesis components by genetic mutations (for example ERG11, ERG2, ERG3), regulation of transcriptional factors related to sterol response UPC2 in C. albicans (Flowers et al., 2012; Silver et al., 2004) and SRE1 in C. neoformans (Chang et al., 2009); expressi…”
BackgroundEfungumab and caspofungin: pre-clinical data supporting synergy.
Hodgetts, S., Nooney, L., Al-Akeel, R., Curry, A., Awad, S., Matthews, R., & Burnie, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn075 · Cited by 51
“Resistance to caspofungin has been increasingly reported and hsp90 is implicated in this process.(14,15,19) This raises the question as to whether the addition of efungumab to caspofungin therapy will increase susceptibility and lead to an improvement in the overall treatment success rates.”
BackgroundExploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design
Pizarro, J. C., Hills, T. L., Senisterra, G. A., Wernimont, A. K., Mackenzie, C. J., Norcross, N. R., Ferguson, M. A. J., Wyatt, P. G., Gilbert, I. H., & Hui, R. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002492 · Cited by 50
“Finally, a role has been determined for this chaperone in Candida albicans in the resistant phenotypes against commonly used antifungal drugs, then a plausible hypothesis could be that the parasitic hyperactive Hsp90 could facilitate the emergence of drug resistant parasites [50,51].”
BackgroundThe Nature of Nurture and the Future of Evodevo: Toward a Theory of Developmental Evolution
Moczek, A. P. (2012) · Integrative and Comparative Biology · doi:10.1093/icb/ics048 · Cited by 54
“Ample evidence now exists that conditionally neutral genetic variation is widespread, releasable under novel or stressful environmental conditions, and sufficient to fuel the rapid, selective evolution of novel forms (Rutherford and Lindquist 1998; Queitsch et al. 2002; Cowen and Lindquist 2005; Suzuki and Nijhout 200…”
BackgroundPais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 54
“albicans isolates to evaluate the impact of the essential chaperone Hsp90 in the natural evolutionary process [96].”
BackgroundAntifungal resistance in Aspergillus terreus: A current scenario
Vahedi‐Shahandashti, R., & Lass‐Flörl, C. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103247 · Cited by 54
DNA Replication Error-Induced Extinction of Diploid Yeast
Herr, A. J., Kennedy, S. R., Knowels, G. M., Schultz, E. M., & Preston, B. D. (2014) · Genetics · doi:10.1534/genetics.113.160960 · Cited by 58
“…including the tolerance of protein structures to amino acid substitutions (Wagner 2000), the capacity of chaperones to assist folding and function of mutant proteins (Cowen and Lindquist 2005), and the flexibility of metabolic networks to compensate for genetic deficiencies (Harrison et al. 2007).”
BackgroundInhibiting mitochondrial phosphate transport as an unexploited antifungal strategy
McLellan, C. A., Vincent, B. M., Solis, N. V., Lancaster, A. K., Sullivan, L. B., Hartland, C. L., Youngsaye, W., Filler, S. G., Whitesell, L., & Lindquist, S. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2534 · Cited by 49
“As previously reported, ML316 (1) exhibited more potent antifungal activity against azoleresistant C.”
BackgroundSelf-citationO’Meara, T. R., O’Meara, M. J., Polvi, E. J., Pourhaghighi, M. R., Liston, S. D., Lin, Z.-Y., Veri, A. O., Emili, A., Gingras, A.-C., & Cowen, L. E. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000358 · Cited by 49
Self-citationMass Spectrometry for Proteomics-Based Investigation of Oxidative Stress and Heat Shock Proteins
Sokolowska, I., Woods, A. G., Wagner, J. S., Dorler, J., Wormwood, K. L., Thome, J., & Darie, C. C. (2011) · ACS symposium series · doi:10.1021/bk-2011-1083.ch013 · Cited by 51
Tan, X., Sun, J., Ning, H., Qin, Z., Miao, Y., Sun, T., & Zhang, X. (2018) · Gene · doi:10.1016/j.gene.2018.03.093 · Cited by 49
O'Meara, T. R., & Cowen, L. E. (2014) · Cellular Microbiology · doi:10.1111/cmi.12266 · Cited by 48
“…such as the protein phosphatase calcineurin or elements of the protein kinase C (PKC) pathway, Hsp90 enables the phenotypic effects of resistance mutations, and thus the development of drug resistance (Cowen and Lindquist, 2005; Cowen et al., 2006; Singh et al., 2009; Singh-Babak et al., 2012).”
BackgroundSelf-citationXie, J. L., Bohovych, I., Wong, E. O. Y., Lambert, J., Gingras, A., Khalimonchuk, O., Cowen, L. E., & Leach, M. D. (2017) · Microbial Cell · doi:10.15698/mic2017.10.594 · Cited by 49
“albicans [22, 24, 26, 55], but the roles of other chaperones remain largely unknown.”
BackgroundSelf-citationCRISPR-Based Genetic Manipulation of Candida Species: Historical Perspectives and Current Approaches
Uthayakumar, D., Sharma, J., Wensing, L., & Shapiro, R. S. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.606281 · Cited by 56
“…to study essential genes and was applied to repress HSP90, an essential molecular chaperone in C. albicans, and demonstrated that CRISPRi-based HSP90 repression renders strains sensitive to antifungal agents (Wensing et al., 2019), in accordance with previous studies (Cowen and Lindquist, 2005).”
ResultRoles of Hsp90 in Candida albicans morphogenesis and virulence
Robbins, N., & Cowen, L. E. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102351 · Cited by 58
“Thus far, we have highlighted the pivotal role of fungal Hsp90 in enabling morphogenesis and virulence, as well as touched on the importance of this molecular chaperone in governing resistance to both the azoles and echinocandins in diverse fungal pathogens [4,30,41,43–45].”
BackgroundSelf-citationTerbinafine Resistance in Trichophyton rubrum and Trichophyton indotineae: A Literature Review
Gupta, A. K., Susmita, S., Nguyen, H. C., Liddy, A., Economopoulos, V., & Wang, T. (2025) · Antibiotics · doi:10.3390/antibiotics14050472 · Cited by 54
“Crz1, a key downstream effector, links calcineurin activation to azole resistance in Candida albicans ( C. albicans ) [91,92,105].”
Wang, T., Mäser, P., & Picard, D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00591 · Cited by 47
Azole resistance in Aspergillus fumigatus- comprehensive review
Dladla, M., Gyzenhout, M., Marais, G. J., & Ghosh, S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04026-z · Cited by 50
“The role of Hsp90 in the onset and maintenance of azole resistance is well established from the model yeast Saccharomyces cerevisiae (Cowen and Lindquist 2005).”
InfluentialLee, H., Lamichhane, A. K., Garraffo, H. M., Kwon-Chung, K. J., & Chang, Y. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08016.x · Cited by 53
“This article is a U.S. Government work and is in the public domain in the USA. to drug stress (Cowen and Lindquist, 2005; Cowen et al., 2006).”
A prescription for ‘stress’ – the role of Hsp90 in genome stability and cellular adaptation
Kaplan, K. B., & Li, R. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.006 · Cited by 56
Post-transcriptional Repair of a Split Heat Shock Protein 90 Gene by mRNA trans-Splicing
Nageshan, R. K., Roy, N., Hehl, A. B., & Tatu, U. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.208389 · Cited by 46
Viewing Protein Fitness Landscapes Through a Next-Gen Lens
Boucher, J. I., Cote-Hammarlof, P. A., Flynn, J. M., Jiang, L., Laban, A., Mishra, P., Roscoe, B. P., & Bolon, D. N. A. (2014) · Genetics · doi:10.1534/genetics.114.168351 · Cited by 50
“Consistent with this idea, reducing Hsp90 levels reveals phenotypic effects for many otherwise “ cryptic ” mutations in yeast (Cowen and Lindquist 2005).”
BackgroundRichardson, J. B., Uppendahl, L. D., Traficante, M. K., Levy, S. F., & Siegal, M. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003733 · Cited by 48
“Our results are reminiscent of work on Hsp90 in yeast, even though that work was conducted with strains that had been subject to natural selection [23,52].”
Reassessing the Use of Undecanoic Acid as a Therapeutic Strategy for Treating Fungal Infections
Rossi, A., Martins, M. P., Bitencourt, T. A., Peres, N. T. A., Rocha, C. H. L., Rocha, F. M. G., Neves‐da‐Rocha, J., Lopes, M. E. R., Sanches, P. R., Bortolossi, J. C., et al. (2021) · Mycopathologia · doi:10.1007/s11046-021-00550-4 · Cited by 51
“Events of environmentally induced resistance occurring before genetic resistance are well described and pose a real challenge for antifungal therapy [67, 68].”
BackgroundMetcalf, S. C., & Dockrell, D. H. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.06.012 · Cited by 52
Jia, X. M., Wang, Y., Jia, Y., Gao, P. H., Xu, Y. G., Wang, L., Cao, Y. Y., Cao, Y. B., Zhang, L. X., & Jiang, Y. Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8409-3 · Cited by 45
Kumar, R., Pavithra, S. R., & Tatu, U. S. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0052-x · Cited by 45
“In addition, a recent report has identifi ed a role for Hsp90 in the potentiation of drug resistance in Candida albicans ( Cowen and Lindquist 2005 ).”
BackgroundParedes, J. A., Carreto, L. C., Simões, J., Bezerra, A. R., Gomes, A. C., Santamaría, R., Kapushesky, M., Moura, G. R., & Santos, M. A. S. (2012) · BMC Biology · doi:10.1186/1741-7007-10-55 · Cited by 46
“Disruption of Hsp90 interconnectivity through gene deletions, chemical inhibition or functional overloading, resulted in extensive phenotypic variation (including drug resistance) in yeast, fungi, Drosophila melanogaster and Arabidopsis thaliana [86-89].”
BackgroundReed, R. D., Chen, P., & Nijhout, H. F. (2007) · Evolution & Development · doi:10.1111/j.1525-142x.2006.00133.x · Cited by 46
Borah, S., Shivarathri, R., & Kaur, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264671 · Cited by 44
Hosfelt, J., Richards, A., Zheng, M., Adura, C., Nelson, B., Yang, A., Fay, A., Resager, W., Ueberheide, B. M., Glickman, J. F., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.004 · Cited by 46
“, 2014) and fungi (Cowen and Lindquist, 2005; Vincent et al., 2013), primarily through disruption of the eukaryotic chaperone Hsp90 (Nitika et al.”
BackgroundGenerators of Phenotypic Diversity in the Evolution of Pathogenic Microorganisms
Calo, S., Billmyre, R. B., & Heitman, J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003181 · Cited by 53
“Hsp90 can also act as a potentiator of variability by: 1) chaperoning mutated cell regulators that are prone to misfolding, or 2) through its interaction with the cell signaling regulator calcineurin, allowing new traits such as drug resistance to appear in a diverse range of fungal species [23].”
BackgroundHeat Shock Proteins in Histoplasma and Paracoccidioides
Cleare, L. G., Zamith‐Miranda, D., & Nosanchuk, J. D. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00221-17 · Cited by 48
“albicans enables the development of a drug-resistant phenotype, while its inhibition abrogates the emergence of resistance (60, 62).”
BackgroundHDAC Inhibitors and Chaperone Function
Rao, R., Fiskus, W. C., Ganguly, S., Kambhampati, S., & Bhalla, K. N. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394387-3.00007-0 · Cited by 47
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance
Shahinas, D., Folefoc, A., & Pillai, D. R. (2013) · Pathogens · doi:10.3390/pathogens2010033 · Cited by 55
“, ergosterol and cell wall biosynthesis) [47,67].”
BackgroundInfluentialProgress and prospects for targeting Hsp90 to treat fungal infections
Veri, A. O., & Cowen, L. E. (2014) · Parasitology · doi:10.1017/s0031182013002072 · Cited by 49
“In C. albicans, the first Hsp90 client protein identified was calcineurin (Cowen and Lindquist, 2005; Cowen et al. 2006; Singh et al. 2009), a serine threonine protein phosphatase and key regulator of resistance to azoles and echinocandins (Cruz et al. 2002; Sanglard et al. 2003; Singh et al. 2009).”
BackgroundResultInfluentialSelf-citationLi, X., Robbins, N., O’Meara, T. R., & Cowen, L. E. (2016) · Molecular Microbiology · doi:10.1111/mmi.13578 · Cited by 53
“Although hyperactivity of drug efflux transporters could simply cause increased efflux of GdA or TSA, we previously established that genetic depletion of Hsp90 does not reduce resistance acquired by overexpression of ABC-transporters in S. cerevisiae (Cowen and Lindquist, 2005).”
BackgroundInfluentialSelf-citationLi, X., Yu, C., Huang, X., & Sun, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168936 · Cited by 44
The heat shock proteins: Their roles as multi-component machines for protein folding
Panaretou, B., & Zhai, C. (2008) · Fungal Biology Reviews · doi:10.1016/j.fbr.2009.04.002 · Cited by 50
Jarosz, D. F. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.11.001 · Cited by 43
O’Meara, T. R., Veri, A. O., Polvi, E. J., Li, X., Valaei, S. F., Diezmann, S., & Cowen, L. E. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006142 · Cited by 42
Self-citationHsp70-associated chaperones have a critical role in buffering protein production costs
Farkas, Z. J., Kalapis, D., Bódi, Z., Szamecz, B., Daraba, A., Almási, K., Kovács, K., Boross, G. Z., Pál, F., Horváth, P., et al. (2018) · eLife · doi:10.7554/elife.29845 · Cited by 48
“More generally, several molecular chaperones can buffer the damaging effects of protein mutations (Csermely, 2001; Queitsch et al., 2002; Cowen and Lindquist, 2005; Paaby and Rockman, 2014).”
BackgroundDecanalizing thinking on genetic canalization
Geiler‐Samerotte, K., Sartori, F. M. O., & Siegal, M. L. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.008 · Cited by 42
“Our current expectation is that genes under stabilizing selection will tend to accumulate buffered genetic variation [5] whereas genes that experienced recent adaptive evolution will be enriched for potentiated variants [56,58].”
BackgroundInfluentialEmerging Mechanisms of Drug Resistance in Candida albicans
Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 45
Novel Antifungal Agents and Their Activity against Aspergillus Species
Vahedi‐Shahandashti, R., & Lass‐Flörl, C. (2020) · Journal of Fungi · doi:10.3390/jof6040213 · Cited by 51
Heitman, J. (2005) · Science · doi:10.1126/science.1119321 · Cited by 48
Chen, S. C.-A., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Virulence · doi:10.4161/viru.2.4.16764 · Cited by 41
A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
Shahinas, D., Folefoc, A., Taldone, T., Chiosis, G., Crandall, I., & Pillai, D. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075446 · Cited by 41
“Several studies indicate that Hsp90 clients are essential proteins within abnormal cells [1,3,9,12,15,16].”
BackgroundResultEdwards, J. A., Zemska, O., & Rappleye, C. A. (2011) · Infection and Immunity · doi:10.1128/iai.05124-11 · Cited by 44
“types ranging from cancer to antifungal drug resistance (6, 39).”
BackgroundEvolutionary divergence in the fungal response to fluconazole revealed by soft clustering
Kuo, D., Tan, K., Zinman, G., Ravasi, T., Bar‐Joseph, Z., & Ideker, T. (2010) · Genome biology · doi:10.1186/gb-2010-11-7-r77 · Cited by 41
“Cowen LE, Carpenter AE, Matangkasombut O, Fink GR, Lindquist S: Genetic architecture of Hsp90-dependent drug resistance.”
Potential Microbiological Effects of Higher Dosing of Echinocandins
Steinbach, W. J., Lamoth, F., & Juvvadi, P. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ725 · Cited by 48
A genome-wide steroid response study of the major human fungal pathogen Candida albicans
Banerjee, D., Martin, N., Nandi, S., Shukla, S., Domínguez, Á., Mukhopadhyay, G., & Prasad, R. (2007) · Mycopathologia · doi:10.1007/s11046-007-9025-8 · Cited by 43
“Other genes like IPF3370 (similar to S. cerevisiae Pre1p 20S proteasome subunit), IPF6629 (AHP1, response to oxidative stress) were oppositely regulated (induced by progesterone and repressed by Amp-B).”
BackgroundInfluentialMount, H. O., Revie, N. M., Todd, R. T., Anstett, K., Collins, C., Costanzo, M., Boone, C., Robbins, N., Selmecki, A., & Cowen, L. E. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007319 · Cited by 34
Self-citationFeng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Metabolic control of antifungal drug resistance
Robbins, N., Collins, C., Morhayim, J., & Cowen, L. E. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.07.004 · Cited by 40
Self-citationMarcyk, P. T., LeBlanc, E. V., Kuntz, D. A., Xue, A., Ortiz, F., Trilles, R., Bengtson, S., Kenney, T. M. G., Huang, D. S., Robbins, N., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01777 · Cited by 40
Self-citationHost proteostasis modulates influenza evolution
Phillips, A. M., González, L. O., Nekongo, E. E., Ponomarenko, A. I., McHugh, S. M., Butty, V. L., Levine, S. S., Lin, Y., Mirny, L. A., & Shoulders, M. D. (2017) · eLife · doi:10.7554/elife.28652 · Cited by 42
“Important work focused primarily on the Hsp90 chaperone has suggested a critical role for chaperones in modulating the evolution of their endogenous clients, (Cowen and Lindquist, 2005; Queitsch et al., Phillips et al. eLife 2017;6:e28652.”
BackgroundInfluentialGlobal mistranslation increases cell survival under stress in Escherichia coli
Samhita, L., Raval, P. K., & Agashe, D. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008654 · Cited by 41
“Similarly, changes in Hsp90 levels in Candida albicans [51] and at least one phenotype conferred by the prion PSI+ in wild yeasts can be stabilised over evolutionary time [52].”
BackgroundHsp90 modulates CAG repeat instability in human cells
Mittelman, D., Sykoudis, K., Hersh, M. N., Lin, Y., & Wilson, J. H. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0191-0 · Cited by 42
“2007), of which a subset can be selected to accommodate environmental pressure (Cowen and Lindquist 2005).”
BackgroundHsp90 Regulates Nongenetic Variation in Response to Environmental Stress
Hsieh, Y.-Y. P., Hung, P.-H., & Leu, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.026 · Cited by 40
“Waddington: phenotypic invariance in spite of genetic or environmental perturbations during organismal development (Cowen and Lindquist, 2005; Jarosz et al., 2010; Waddington, 1942).”
BackgroundSystematic Analysis of the Lysine Acetylome in Candida albicans
Zhou, X., Qian, G., Yi, X., Li, X., & Liu, W. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00052 · Cited by 39
Tamayo, D. P., Muñoz, J. F., Torres, I. P., Almeida, A. J., Restrepo, Á., McEwen, J. G., & Hernández, O. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.11.005 · Cited by 41
Thermoregulation in the life cycle of nematodes
Devaney, E. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2006.02.006 · Cited by 40
Fungal resilience and host–pathogen interactions: Future perspectives and opportunities
Brown, A. J. P. (2022) · Parasite Immunology · doi:10.1111/pim.12946 · Cited by 46
“adaptation to changes in nutrients or stress imposition strongly influences the resistance of Candida to antifungal drugs.(8,118) Significantly,”
BackgroundHokken, M., Zoll, J., Coolen, J. P. M., Zwaan, B. J., Verweij, P. E., & Melchers, W. J. G. (2019) · BMC Genomics · doi:10.1186/s12864-018-5255-z · Cited by 40
“Many mechanisms that cope with cell stress respond to various stressful conditions, and are not limited to a specific stress condition or a specific antifungal compound [47, 83, 84].”
BackgroundRocha, M. C., Minari, K., Fabri, J. H. T. M., Kerkaert, J. D., Gava, L. M., da Cunha, A. F., Cramer, R. A., Borges, J. C., & Malavazi, I. (2020) · Cellular Microbiology · doi:10.1111/cmi.13273 · Cited by 43
Molecular chaperones: The modular evolution of cellular networks
Korcsmáros, T., Kovács, I. A., Szalay, M., & Csermely, P. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0043-y · Cited by 45
“Arabidopsis thaliana and the evolution of resistance in fungi ( Cowen and Lindquist, 2005; Fares et al., 2002; Queitsch et al., 2002).”
Dai, B., Wang, Y., Li, D., Xu, Y., Liang, R., Zhao, L., Cao, Y., Jia, J., & Jiang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045109 · Cited by 37
Emerging drugs and vaccines for Candidemia
Moriyama, B., Gordon, L. A., McCarthy, M. W., Henning, S. A., Walsh, T. J., & Penzak, S. R. (2014) · Mycoses · doi:10.1111/myc.12265 · Cited by 45
Triple-aspect monism: A conceptual framework for the science of human consciousness
Pereira, A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139207065.011 · Cited by 49
HSP90 Stabilizes Auxin-Responsive Phenotypes by Masking a Mutation in the Auxin Receptor TIR1
Watanabe, E., Mano, S., Nomoto, M., Tada, Y., Hara‐Nishimura, I., Nishimura, M., & Yamada, K. (2016) · Plant and Cell Physiology · doi:10.1093/pcp/pcw170 · Cited by 41
Blum, G., Kainzner, B., Grif, K., Dietrich, H., Zeiger, B., Sonnweber, T., & Lass‐Flörl, C. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03848.x · Cited by 37
Metadata
- Authors
- Cowen, L. E., & Lindquist, S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Lindquist, Susan
- ORCID
- Cowen, Leah E.
- Venue
- Science
- Published
- 2005-09-30
- Volume
- 309
- Issue
- 5744
- Pages
- 2185-2189
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1988825409
- Cited by
- 698
- References
- 36
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 46 · 2023: 30 · 2022: 30 · 2021: 38 · 2020: 34 · 2019: 42 · 2018: 36 · 2017: 25 · 2016: 34 · 2015: 36 · 2014: 39 · 2013: 40 · 2012: 47
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (P30ES002109, P30ES-02109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- HSP90, molecular chaperones, drug resistance, fungi, Hsp90 inhibitors, fever, febrile temperature, signal transducers, treatment options
- MeSH terms
- Caspofungin, Antifungal Agents, Aspergillosis, Aspergillus, Candida albicans, Candidiasis, Ergosterol, Biological Evolution, Humans, Mutation, Peptides, Cyclic, Phenotype, Saccharomyces cerevisiae, Selection, Genetic, Fluconazole, AIDS-Related Opportunistic Infections, HSP90 Heat-Shock Proteins, Calcineurin, Cyclophilin A, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Echinocandins, Lipopeptides, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.